Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), an…

Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period –--Cohort 7 Pharmacokinetic (PK) ...

Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

Tablet PK exposure increases proportionally with an increase in dose ---- More favorable PK properties in tablets enable a ...

Reunert Limited (RNRTY) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call November 21, 2025 2:00 AM ESTCompany ParticipantsAlan Dickson - Group CEO & Executive DirectorK.

Pfizer: Is This Pharma Giant Finally A Bargain

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.
ascopubs.org

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine ...
eLife

Synaptic density and relative connectivity conservation maintain circuit stability across development

The authors have performed a potentially valuable new kind of analysis in connectomics, mapping to an interesting developmental problem of synaptic input to sensory neurons. While the analysis itself ...

The Biotech Growth Trust PLC - Half-year Financial Report

The Biotech Growth Trust PLC - Half-year Financial Report ...
Cyclingnews.com

Competitive Cyclist coupon codes for November 2025

Save more on high-performance competitive bikes and gear with our 12 verified Competitive Cyclist coupon codes. All coupon content is created by Cyclingnews. We may earn a commission if you buy ...